These findings suggest that disturbed blood flow alters endothelial gene expression and promotes atherosclerosis through DNMT-dependent DNA hypermethylation, highlighting DNMT as a promising therapeutic target for atherosclerosis [27]. This evidence concerns the gene DNMT1 and atherosclerosis.